IntraOp Mobetron Proves An Effective Tool In This First-Time Pancreatic Treatment at VUMC
The procedure was performed by surgical oncologist, Kamran Idrees, MD, MSCI, MMHC, FACS, and radiation oncologist Natalie A Lockney, MD. (Cedit: IntraOp Medical, Inc.)
IntraOp Medical Corporation announced today that doctors at Vanderbilt University Medical Center (VUMC) treated a pancreatic cancer patient using IntraOp Mobetron Intra-Operative Radiation Therapy (IORT). Based in Nashville, Tennessee, and serving the southeast region of the United States, Vanderbilt University Medical Center is the only hospital in the state with this first-of-its-kind technology and the only Center of Excellence for pancreatic cancer as designated by the National Pancreas Foundation.
The procedure marks the first time VUMC — the largest comprehensive research, teaching and patient care health system in the Mid-South region — has utilized IORT with electrons in treating a patient with pancreatic cancer. The procedure was performed by surgical oncologist, Kamran Idrees, MD, MSCI, MMHC, FACS, and radiation oncologist Natalie A Lockney, MD.
“We are encouraged by the results of the IORT with electrons in treating localized pancreatic cancer,” said Dr. Kamran Idrees. “We serve our patients by implementing the latest innovations at Vanderbilt to improve outcomes.”
Pancreatic cancer remains one of the deadliest forms of cancer. As the safest and most advanced portable LINAC available, the IntraOp Mobetron has established itself as an essential treatment tool for this most challenging indication. But it’s the precision of the device that makes it so effective. Due to the location of the pancreas and its proximity to major vessels, duodenum, spinal cord, stomach, small and large bowel, liver and kidneys makes precision critical. IORT with electrons makes precise surgery available for more patients than ever before.
“While this procedure is a first for the extraordinary team at Vanderbilt University Medical Center, it is yet another chapter for the promise of IORT with electrons and our collective fight to better treat pancreatic cancer,” added Sanjay Arora, CEO at IntraOp. “We’re excited to see where this important milestone leads us.”
Source: Company Press Release